These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12529020)

  • 1. Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized.
    Bofin AM; Qvigstad G; Waldum C; Waldum HL
    APMIS; 2002 Sep; 110(9):658-64. PubMed ID: 12529020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
    Radhi JM
    Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
    Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
    Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast.
    Baqai T; Shousha S
    Histopathology; 2003 May; 42(5):440-7. PubMed ID: 12713620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A morphological and immunohistochemical study of ductal carcinoma in situ, invasive breast carcinoma of no special type, and mucinous carcinoma of the breast in comparison with solid papillary carcinoma regarding neuroendocrine marker expression.
    Otsuki Y; Asano Y; Ikeya T; Ishida Y; Sezaki S; Kobayashi H
    Virchows Arch; 2024 Sep; 485(3):547-555. PubMed ID: 38958708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique.
    Qvigstad G; Sandvik AK; Brenna E; Aase S; Waldum HL
    Histochem J; 2000 Sep; 32(9):551-6. PubMed ID: 11127976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
    Yang G; Guo L; Jin H; Li J; Ding H
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-erbB3 protein in primary breast carcinomas.
    Naidu R; Yadav M; Nair S; Kutty MK
    Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl2 expression and its correlation with neuroendocrine differentiation in colon carcinomas.
    Atasoy P; Bozdoğan O; Oztürk S; Ensari A
    Tumori; 2004; 90(2):233-8. PubMed ID: 15237588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in bronchial carcinomas of classic squamous-cell type: an immunohistochemical study of 29 cases applying the tyramide signal amplification technique.
    Fresvig A; Qvigstad G; Halvorsen TB; Falkmer S; Waldum HL
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):9-13. PubMed ID: 11277422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of chromogranin A expression in serum and tissues of breast cancer patients.
    Giovanella L; Marelli M; Ceriani L; Giardina G; Garancini S; Colombo L
    Int J Biol Markers; 2001; 16(4):268-72. PubMed ID: 11820723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cell cohesion in breast cytology as a characteristic of neuroendocrine carcinoma.
    Tang W; Taniguchi E; Wang X; Mori I; Kagiya T; Yang Q; Nakamura Y; Nakamura M; Yoshimura G; Sakurai T; Kakudo K
    Acta Cytol; 2002; 46(5):835-40. PubMed ID: 12365216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma.
    Kimura N; Yoshida R; Shiraishi S; Pilichowska M; Ohuchi N
    Endocr Pathol; 2002; 13(2):117-22. PubMed ID: 12165659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach.
    Ridolfi RL; Jamehdor MR; Arber JM
    Mod Pathol; 2000 Aug; 13(8):866-73. PubMed ID: 10955453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
    Ding HY; Gao LX
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.